Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitor: Comparing Trial Data and Real-World Use

Схожие документы

• Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors: Comparing Trial and Real World Use (Study Protocol)
  по: McGovern, Andrew, et al.
  Опубликовано: (2017)
• Does Renal Function or Heart Failure Diagnosis Affect Primary Care Prescribing for Sodium-Glucose Co-Transporter 2 Inhibitors in Type 2 Diabetes?
  по: Hinton, William, et al.
  Опубликовано: (2020)
• How Generalizable Are Cardiovascular Outcome Trials of Sodium-Glucose Co-Transporter-2 Inhibitors? A National Database Study: Study Protocol
  по: Hinton, William, et al.
  Опубликовано: (2019)
• Prescribing sodium-glucose co-transporter-2 inhibitors for type 2 diabetes in primary care: influence of renal function and heart failure diagnosis
  по: Hinton, William, et al.
  Опубликовано: (2021)
• Sodium–glucose co‐transporter‐2 inhibitor cardiovascular outcome trials and generalizability to English primary care
  по: Hinton, W., et al.
  Опубликовано: (2020)